Belgian developer of bio-manufacturing execution software for GMP production of advanced therapies such as cell and gene therapy.
MyCellHub BV was founded by Sébastien de Bournonville, Thomas Pinna and Toon Lambrechts and is based in Belgium. Its Bio-Manufacturing Execution System digitizes advanced therapy production with electronic batch records, interactive work instructions and regulatory compliance features. It serves cell and gene therapy developers and CDMOs on subscription-based service agreements. The company received EUR 1.1 million in Seed funding from K.U. Leuven Research & Development, Noshaq, The Co-Foundry and The Faktory as of September 12, 2019, and CEO Jacques Parlongue leads the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in